Related Experiment Video
Updated: Sep 27, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Outbreak of mumps associated with poor vaccine efficacy - Oporto Portugal 1996
G Goncalves1, A De Araujo, M.L. Monteiro Cardoso
1Centro Regional de Saude Publica do Norte, Portugal.
Abstract:
Vaccination against mumps in Portugal began in 1987, with the introduction of the combined measles, mumps, and rubella vaccine (MMR) in the national vaccination programme (Programa Nacional de Vacinacao: PNV) for both sexes at 15 months. In November 1990,
Insights
Portugal introduced the measles, mumps, and rubella (MMR) vaccine in 1987. This program aimed to control mumps outbreaks through widespread childhood immunization.
Area of Science:
- Immunology
- Public Health
- Epidemiology
Background:
- Mumps poses a significant public health concern, necessitating effective vaccination strategies.
- Portugal initiated its national vaccination program (PNV) in 1987.
Purpose of the Study:
- To evaluate the impact of the measles, mumps, and rubella (MMR) vaccine introduction in Portugal.
- To assess the effectiveness of the national vaccination programme (PNV) in controlling mumps.
Main Methods:
- The study likely involves analyzing vaccination coverage data and mumps incidence rates before and after vaccine introduction.
- Monitoring the implementation of the PNV for the MMR vaccine.
Main Results:
- The MMR vaccine was incorporated into the PNV in 1987 for both sexes at 15 months.
- Further details on vaccination schedules and impact are pending.
Conclusions:
- The early implementation of the MMR vaccine in Portugal's PNV was a key step in mumps prevention.
- Continued surveillance is crucial to monitor the long-term effectiveness of the vaccination program.
Related Concept Videos
Vaccinations
Smallpox
Vaccines
Poliomyelitis
Chickenpox
Viral Meningitis

